Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch

J Biol Chem. 2014 Oct 10;289(41):28271-83. doi: 10.1074/jbc.M114.585067. Epub 2014 Aug 28.

Abstract

It has recently been appreciated that the angiotensin II type 1 receptor (AT1R), a prototypic member of the G protein-coupled receptor superfamily, also functions as a mechanosensor. Specifically, mechanical stretch activates the AT1R to promote downstream signaling mediated exclusively by the multifunctional scaffold protein, β-arrestin, in a manner consistent with previously identified β-arrestin-biased ligands. However, the ligand-independent mechanism by which mechanical stretch promotes β-arrestin-biased signaling remains unknown. Implicit in the concept of biased agonism (i.e. the ability of an agonist to activate a subset of receptor-mediated signaling pathways) is the notion that distinct active conformations of the receptor mediate differential activation of signaling pathways. Here we determined whether mechanical stretch stabilizes distinct β-arrestin-activating conformations of the AT1R by using β-arrestin2-biased agonists as conformational probes in pharmacological and biophysical assays. When tested at cells expressing the AT1R fused to β-arrestin (AT1R-β-arrestin2), we found that osmotic stretch increased the binding affinity and potency of the β-arrestin-biased agonist TRV120023, with no effect on the balanced agonist AngII. In addition, the effect of osmotic stretch on ERK activation was markedly augmented in cells expressing the AT1R-β-arrestin2 fusion compared with the wild type AT1R and completely blocked in cells expressing the AT1R-Gq fusion. Biophysical experiments with an intramolecular BRET β-arrestin2 biosensor revealed that osmotic stretch and TRV120023 activate AT1Rs to stabilize β-arrestin2 active conformations that differ from those stabilized by the AT1R activated by angiotensin II. Together, these data support a novel ligand-independent mechanism whereby mechanical stretch allosterically stabilizes specific β-arrestin-biased active conformations of the AT1R and has important implications for understanding pathophysiological AT1R signaling.

Keywords: Allosteric Regulation; Angiotensin II; Cell Signaling; Conformational Change; Mechanotransduction.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allosteric Regulation
  • Angiotensin II / chemistry
  • Angiotensin II / genetics
  • Angiotensin II / metabolism*
  • Arrestins / genetics
  • Arrestins / metabolism*
  • Biomechanical Phenomena
  • Biosensing Techniques
  • Cell Membrane / chemistry
  • Cell Membrane / metabolism*
  • Extracellular Signal-Regulated MAP Kinases / chemistry
  • Extracellular Signal-Regulated MAP Kinases / genetics
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Gene Expression Regulation
  • HEK293 Cells
  • Humans
  • Mechanotransduction, Cellular*
  • Oligopeptides / pharmacology
  • Osmotic Pressure
  • Receptor, Angiotensin, Type 1 / agonists*
  • Receptor, Angiotensin, Type 1 / genetics
  • Receptor, Angiotensin, Type 1 / metabolism
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism*
  • beta-Arrestins

Substances

  • Arrestins
  • Oligopeptides
  • Receptor, Angiotensin, Type 1
  • Recombinant Fusion Proteins
  • beta-Arrestins
  • sarcosine-arginyl-valyl-tyrosyl-lysyl-histidyl-prolyl-alanine
  • Angiotensin II
  • Extracellular Signal-Regulated MAP Kinases